Processing Your Payment

Please do not leave this page until complete. This can take a few moments.

April 15, 2021

Marlborough biotech firm raises $115M to roll out insulin device

Courtesy | CeQur The CeQur Simplicity is a wearable insulin device.

Marlborough insulin delivery company CeQur announced Tuesday it had raised $115 million in equity financing.

The company said it will use the funds to advance commercial plans towards a limited market release this year of its CeQur Simplicity wearable insulin device. The three-day device delivers daily injections and can help patients follow their insulin regimens, according to the company. It is both cleared by the U.S. Food and Drug Adminstration and CE-marked by European regulators.

Swiss bank division Credit Suisse Entrepreneur Capital Ltd. and Swiss private equity firm Endeavour Vision led the financing.

Sign up for Enews

WBJ Web Partners

0 Comments

Order a PDF